CTCtrap can capture circulating tumour cells in cancer patients

[News]

The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or colorectal cancer with a high enough degree of reliability. These CTCs are the cause of metastases in cancer patients. If they can be effectively characterized, it is possible to arrive at a prognosis and to determine the most effective course of treatment.

More... (http://www.news-medical.net/news/20121026/CTCtrap-can-capture-circulating-tumour-cells-in-cancer-patients.aspx)